Results 241 to 250 of about 49,735 (302)

Tocilizumab for severe and refractory mucous membrane pemphigoid

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1682-1691, October 2026.
Elevated IL‐6 levels identified in mucous membrane pemphigoid support IL‐6 blockade, with tocilizumab demonstrating clinical benefit in nine patients with severe and refractory mucous membrane pemphigoid. Abstract Background Mucous membrane pemphigoid (MMP) is a rare autoimmune blistering disease involving mucous membranes with a potentially ...
Billal Tedbirt, Maud Maho‐Vaillant, Julie Gueudry, Marie‐Laure Golinski, Marion Marcaillou, Blanche Bergeret, Guillaume Chambon, Pierre Bouchetemble, Soumeya Bekri, Abdellah Tebani, Hervé Maillard, Cécile Morice, Anais Vautier, Edgar‐Pierre Libert, Christelle Le Roux‐Villet, Marion Carrette, Olivier Boyer, Vivien Hébert, Sébastien Calbo, André Gillibert, Pascal Joly   +20 more
wiley   +1 more source

Diagnosis of Post-Infectious Bronchiolitis Obliterans: Guiding Treatment With Infant Pulmonary Function Testing. [PDF]

Pediatr Pulmonol
Angel JR, Guitterez JL, Weiner DJ, Kurland G.   +3 more
europepmc   +1 more source

Acute Scrotal Involvement in Kawasaki Disease: A Potential Clinical Clue to Persistent Disease Activity. [PDF]

Case Rep Pediatr
Inui Y, Yokoi K, Sumida C, Itano M, Hatakawa N, Suzuki T, Uchida H, Saito K, Kawamura Y.   +8 more
europepmc   +1 more source

Severe immune thrombocytopenia induced by vancomycin in a critically ill patient: a case report and literature review. [PDF]

Thromb J
Khoshnam Rad N, Ghasemi F, Firouzbakhsh S, Rashidinejad B.   +3 more
europepmc   +1 more source

Machine learning model for intravenous immunoglobulin resistance in Kawasaki disease: model development and validation study. [PDF]

World J Pediatr
Zhang JY, You TJ, Li J, Dong JF, Xu L, Li X, Hu JL, Tang YJ, Hou M, Liu Y, Xu ZX, Lv HT, Huang HB.   +12 more
europepmc   +1 more source

Unmasking a B-Cell Linkage Phenotype in Severe Acute Meningoencephalitis: A Case Report of IVIG and HydroBox-assisted Immunomodulatory Therapy. [PDF]

In Vivo
Wu CL, Lu JW, Ho YJ, Wu MC, Lui SW, Hsieh TY, Jheng WL, Liu FC.   +7 more
europepmc   +1 more source

Intrathecal IgG synthesis as a biomarker for CNS involvement in anti-GQ1b antibody syndrome: a case report and hypothesis-generating treatment framework. [PDF]

Front Immunol
Zhou H, Guo X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

IVIG – mechanisms of action

Allergy: European Journal of Allergy and Clinical Immunology, 2003
Intravenous immunoglobulin (IVIG) preparations are fractionated from a plasma pool of several thousand donors. IVIG contain immune antibodies and physiologic autoantibodies. Immune antibodies reflect the immunologic experience of the donor population. This fraction of IVIG preparations is useful for replacement therapy and passive immunisation. Natural
H U Simon, P J Spath
exaly   +4 more sources